Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Clopidogrel Formulations in Healthy Adults
NCT02502812Phase 1Completed
- Sponsor
- GSK
- Start
- Sep 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of clopidogrel in cardiovascular disease (CVD) (6 arms), sponsored by GSK. Primary endpoints: Area under the concentration-time curve from time zero to infinity at Day 2, Area under the concentration-time curve from time zero to the last measurable concentration at Day 2 and 1 more. Started Sep 2015; status: completed.
02
Drugs
clopidogrel
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT02502812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502812.